Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1992 3
1993 3
1994 3
1995 2
1996 2
1997 1
1998 4
2000 2
2001 3
2002 2
2003 1
2004 5
2005 5
2006 2
2007 2
2008 4
2009 5
2010 1
2011 2
2012 6
2013 4
2014 4
2015 6
2016 6
2017 5
2018 10
2019 13
2020 16
2021 14
2022 18
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.
Temple WC, Mueller S, Hermiston ML, Burkhardt B. Temple WC, et al. Best Pract Res Clin Haematol. 2023 Mar;36(1):101449. doi: 10.1016/j.beha.2023.101449. Epub 2023 Feb 16. Best Pract Res Clin Haematol. 2023. PMID: 36907639 Free article. Review.
Lymphoblastic lymphoma (LBL) is the second most common type of non-Hodgkin Lymphoma (NHL) in children, adolescents, and young adults (CAYA), accounting for 25-35% of all cases. T-lymphoblastic lymphoma (T-LBL) comprises 70-80% of cases, while precursor …
Lymphoblastic lymphoma (LBL) is the second most common type of non-Hodgkin Lymphoma (NHL) in children, adolescents, and young adul …
Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia.
Harvey RC, Tasian SK. Harvey RC, et al. Blood Adv. 2020 Jan 14;4(1):218-228. doi: 10.1182/bloodadvances.2019000163. Blood Adv. 2020. PMID: 31935290 Free PMC article. Review.
Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (Ph-like ALL) accounts for 15% to 30% of B-cell acute lymphoblastic leukemia in older children, adolescents, and adults and is associated …
Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (Ph-like ALL) accounts for 15% to 30% of …
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL.
Del Bufalo F, Becilli M, Rosignoli C, De Angelis B, Algeri M, Hanssens L, Gunetti M, Iacovelli S, Li Pira G, Girolami E, Leone G, Lazzaro S, Bertaina V, Sinibaldi M, Di Cecca S, Iaffaldano L, Künkele A, Boccieri E, Del Baldo G, Pagliara D, Merli P, Carta R, Quintarelli C, Locatelli F. Del Bufalo F, et al. Blood. 2023 Jul 13;142(2):146-157. doi: 10.1182/blood.2023020023. Blood. 2023. PMID: 37172203
Autologous CD19-directed chimeric antigen receptor (CAR)-T cells have shown unprecedented efficacy in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, patients either relapsing after allo …
Autologous CD19-directed chimeric antigen receptor (CAR)-T cells have shown unprecedented efficacy in children with relapsed/refractory B …
Modern Classification and Management of Pediatric B-cell Leukemia and Lymphoma.
Kovach AE, Raca G. Kovach AE, et al. Surg Pathol Clin. 2023 Jun;16(2):249-266. doi: 10.1016/j.path.2023.01.001. Epub 2023 Mar 8. Surg Pathol Clin. 2023. PMID: 37149359 Review.
Although pediatric hematopathology overlaps with that of adults, certain forms of leukemia and lymphoma, and many types of reactive conditions affecting the bone marrow and lymph nodes, are unique to children. As part of this series focused on lymphomas, this articl …
Although pediatric hematopathology overlaps with that of adults, certain forms of leukemia and lymphoma, and many types of rea …
Tisagenlecleucel-T for the treatment of acute lymphocytic leukemia.
Thomas X, Paubelle E. Thomas X, et al. Expert Opin Biol Ther. 2018 Nov;18(11):1095-1106. doi: 10.1080/14712598.2018.1533951. Epub 2018 Oct 12. Expert Opin Biol Ther. 2018. PMID: 30296188 Review.
The most advanced approach in clinical development is the use of anti-CD19 CAR T-cells for the treatment of CD19(+) B-cell malignancies, including acute lymphocytic leukemia (ALL). ...However, this approach is likely to become a standard option …
The most advanced approach in clinical development is the use of anti-CD19 CAR T-cells for the treatment of CD19(+) B-cell mal …
CAR-T cell persistence in the treatment of leukemia and lymphoma.
Gupta A, Gill S. Gupta A, et al. Leuk Lymphoma. 2021 Nov;62(11):2587-2599. doi: 10.1080/10428194.2021.1913146. Epub 2021 Apr 19. Leuk Lymphoma. 2021. PMID: 33872091 Review.
Food and Drug Administration in 2017 for the treatment of pediatric B cell acute lymphoblastic leukemia and for diffuse large B cell lymphoma (DLBCL), followed recently by mantle cell lymphoma. While long-term immunosurveill …
Food and Drug Administration in 2017 for the treatment of pediatric B cell acute lymphoblastic leukemia a …
Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia.
Leahy AB, Elgarten CW, Grupp SA, Maude SL, Teachey DT. Leahy AB, et al. Expert Rev Anticancer Ther. 2018 Oct;18(10):959-971. doi: 10.1080/14737140.2018.1512411. Expert Rev Anticancer Ther. 2018. PMID: 30111196 Free PMC article. Review.
Cure rates for pediatric and young adult patients with refractory or recurrently relapsed acute lymphoblastic leukemia (ALL) are dismal. ...To date, the only definitive curative therapy has been allogeneic hematopoietic stem cell transpla …
Cure rates for pediatric and young adult patients with refractory or recurrently relapsed acute lymphoblastic leukem …
Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
Nie G, Sun L, Zhang C, Yuan Y, Mao H, Wang Z, Li J, Duan S, Xing C, Zhang B. Nie G, et al. Front Immunol. 2022 Sep 12;13:903315. doi: 10.3389/fimmu.2022.903315. eCollection 2022. Front Immunol. 2022. PMID: 36172352 Free PMC article.
METHODS: We retrospectively reviewed the renal pathology profiles from January 2010 to December 2021, and 28 patients with B-cell LPD combined with intact renal biopsy data were included. ...According to hematological diagnosis, patients were classified into four gr …
METHODS: We retrospectively reviewed the renal pathology profiles from January 2010 to December 2021, and 28 patients with B-cell …
Approach to the Treatment of Philadelphia Chromosome-Negative B-cell ALL in Older Adults: Is Age Becoming just a Number?
Liu Y, Duong VH. Liu Y, et al. Curr Hematol Malig Rep. 2023 Jun;18(3):68-74. doi: 10.1007/s11899-023-00691-x. Epub 2023 Mar 6. Curr Hematol Malig Rep. 2023. PMID: 36877337 Review.
PURPOSE OF REVIEW: Despite progress in the treatment of pediatric B-cell acute lymphoblastic leukemia (ALL) and PH + ALL, fewer advancements have been for older adults with PH-negative B-cell ALL. ...The introduction of nove …
PURPOSE OF REVIEW: Despite progress in the treatment of pediatric B-cell acute lymphoblastic leukemia (AL …
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R, Bergugnat H, Pastoret C, Pasquier F, Raffoux E, Larcher L, Passet M, Grardel N, Delabesse E, Kubetzko S, Caye-Eude A, Meyer C, Marschalek R, Lafage-Pochitaloff M, Thiebaut-Bertrand A, Balsat M, Escoffre-Barbe M, Blum S, Baumann M, Banos A, Straetmans N, Gallego-Hernanz MP, Chalandon Y, Graux C, Soulier J, Leguay T, Hunault M, Huguet F, Lhéritier V, Dombret H, Boissel N, Clappier E. Kim R, et al. Blood. 2023 Nov 23;142(21):1806-1817. doi: 10.1182/blood.2023021501. Blood. 2023. PMID: 37595275 Free article.
KMT2A-rearranged (KMT2A-r) B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is widely recognized as a high-risk leukemia in both children and adults. ...Of 1091 adult patients with Philadelphia-negative BCP-ALL …
KMT2A-rearranged (KMT2A-r) B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is widely recog …
152 results